Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Jun 2, 2017

30870_dirs_2017-06-02_f1859eb4-baeb-44c1-95cc-4031d5b054c2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-06-01

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-06-01 Common Stock S 100 $13.4 Disposed 94785 Direct
2017-06-01 Common Stock S 468 $13.45 Disposed 94317 Direct
2017-06-01 Common Stock S 500 $13.5 Disposed 93817 Direct
2017-06-01 Common Stock S 932 $13.55 Disposed 92885 Direct
2017-06-01 Common Stock S 800 $13.6 Disposed 92085 Direct
2017-06-01 Common Stock S 700 $13.65 Disposed 91385 Direct
2017-06-01 Common Stock S 200 $13.7 Disposed 91185 Direct
2017-06-01 Common Stock S 800 $13.75 Disposed 90385 Direct
2017-06-01 Common Stock S 400 $13.8 Disposed 89985 Direct
2017-06-01 Common Stock S 100 $13.85 Disposed 89885 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.